查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球 PCR 技術市場評估：按產品、技術、應用、最終用戶、地區、機會、預測（2017-2031 年）
市場調查報告書
商品編碼
1408046

全球 PCR 技術市場評估：按產品、技術、應用、最終用戶、地區、機會、預測（2017-2031 年）

Global PCR Technologies Market Assessment, By Product, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 217 Pages | 商品交期: 3-5個工作天內

價格

全球PCR技術市場規模預計到2023年將達到150.5億美元，到2031年將達到297.5億美元，2024-2031年預測期間複合年增長率為8.89%。我是。 分子生物學、生命科學和生物技術領域的市場正在快速成長。 由於PCR在臨床疾病診斷和基因/分子檢測中的使用越來越多，市場正在擴大。 近年來，需要PCR技術進行診斷的肝炎、流感、HIV感染和COVID-19等傳染病的盛行率不斷上升，推動了全球PCR技術市場的需求。

數位 PCR (dPCR) 和即時 PCR (qPCR) 等 PCR 技術的進步帶來了試劑消耗更低、工作流程自動化以及更高的重現性和準確性等優勢，推動了 PCR 技術的採用。推動市場成長。 新興國家市場滲透率的提高和市場上有吸引力的機會正在導致融資和投資的增加。 隨著投資者和市場參與者興趣的增加，供給和需求都顯著增加。 此外，政府對研發的支持也進一步促進了市場的發展。 然而，PCR設備的高成本、PCR技術的技術限制以及缺乏熟練的專業人員來執行協議是市場的主要限制因素。

傳染病和遺傳性疾病的盛行率不斷上升

肝炎、流感和愛滋病毒等傳染病患者病率的增加是 PCR 技術市場的關鍵驅動因素。 傳染病和遺傳性疾病的增加導致對 PCR 技術的需求增加，因為它在這些疾病的診斷和監測中發揮重要作用。 PCR 廣泛用於檢測各種傳染原，包括病毒、細菌和真菌，使其成為傳染病管理的重要工具。 PCR技術也用於檢測導致遺傳性疾病的基因異常，進一步推動市場成長。

根據世界衛生組織的數據，截至 2022 年底，約有 3,900 萬人感染愛滋病毒，其中包括約 150 萬 0 至 14 歲的兒童。 季節性冬季流感可感染高達 20% 的人口並導致大量死亡。 根據世界衛生組織的數據，與季節性流感相關的呼吸道疾病每年導致全球 65 萬人死亡。

擴大臨床診斷與基因/分子檢測的應用

PCR技術在臨床診斷領域具有多種實際應用，近年來隨著研究和開發的增加，PCR應用顯著擴展。 PCR技術廣泛用於COVID-19診斷，推動市場需求。 PCR 技術的顯著應用包括廣譜病原體檢測、新興傳染病的評估和監測、生物威脅的早期檢測以及抗菌素抗藥性分析。 市場參與者正在針對 PCR 技術的新應用推出創新產品。

試劑和消耗品領域預計將主導市場

試劑和消耗品領域預計將在預測期內快速成長。 PCR檢測所使用的設備是一次性投資，而試劑和耗材是重複消耗和購買的，這使其成為關鍵的收入驅動力。 引子、聚合□、核甘酸、反應緩衝液等試劑，以及孔板、吸頭等耗材，在每次PCR過程中都會消耗殆盡，需要在下一次檢測時重新填充，很難上市，我們正在獲取經常性收入。

北美預計引領 PCR 技術市場

北美在全球 PCR 市場中佔據主導地位，其中美國和加拿大佔據最大的市場份額。 該地區的優勢源自於廣泛的研究基礎設施和完善的監管框架等因素，可加快新療法的批准。 該地區主要製藥和生物技術公司的存在正在推動 PCR 技術的開發和採用。 此外，北美在 PCR 研究和開發方面吸引了大量投資，從而可以建立最先進的設施並獲得先進技術。

本報告研究和分析了全球PCR技術市場，提供市場規模和預測、市場動態、主要公司趨勢和展望等。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第四章全球PCR技術市場展望（2017-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 按產品
    • 設備
    • 試劑
    • 消耗品
    • 軟體、服務
    • 其他
  • 按技術
    • 常規 PCR
    • qPCR（實時 PCR）
    • dPCR（數位 PCR）
    • 其他 PCR 技術
  • 依用途
    • 研究用途
    • 診斷用途
    • 其他
  • 按最終用戶
    • 醫院
    • 診斷中心
    • 製藥公司、生技公司
    • 臨床研究所
    • 學術研究所
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 5 章 全球 PCR 技術市場前景：按地區劃分（2017-2031 年）

  • 北美
    • 市場規模與預測
    • 按產品
    • 按技術
    • 依用途
    • 按最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美洲
    • 巴西
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 6 章市場地圖（2023 年）

  • 透過治療
  • 按技術
  • 依用途
  • 按最終用戶
  • 按地區

第七章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析 - 數量與價值
  • 供應/價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制因素）

第 9 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新技術

第十章公司主要情況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家公司進入市場）
  • 專利分析（如果適用）

第11章價格分析

第 12 章案例研究

第十三章主要公司展望

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Promega Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • QIAGEN
  • QuantuMDx Group Ltd
  • Eppendorf

第 14 章策略建議

第十五章關於我們公司，免責聲明

Product Code: MX10842

Global PCR technologies market size was valued at USD 15.05 billion in 2023, and is expected to reach USD 29.75 billion in 2031, with a CAGR of 8.89% for the forecast period between 2024 and 2031F. The Polymerase Chain Reaction technologies market is a rapidly growing field in molecular biology, life sciences, and biotechnology. The PCR technologies market is expanding owing to the increasing application of PCR in clinical disease diagnosis and genetic and molecular testing. The prevalence of infectious diseases like hepatitis, influenza, HIV infection, and COVID-19 infection which require PCR techniques for diagnosis, have been on the rise in recent years, driving demand in the global PCR technologies market.

Advancements in PCR techniques, such as digital PCR (dPCR) and real-time PCR (qPCR), offer benefits like low reagent consumption, automation of workflow, and greater reproducibility and precision, which are encouraging the adoption of PCR technologies, further fueling the market growth. Growing market penetration in emerging countries and attractive opportunities in the PCR technologies market have led to increased funding and investments. With increasing interest from investors and market players, the demand and supply both are significantly increasing. Additionally, government support for research and development is further encouraging market development. However, the high cost of PCR instruments, technical limitations of PCR technology, and lack of skilled professionals to perform the protocols are major restraints for the global PCR technologies market.

In November 2023, QIAGEN announced the launch of three new kits (QIAcuity Mycoplasma Quant Kit, QIAcuity OneStep Advanced EG Kit, and QIAcuity Mericon Food Testing Kits) for using them with its QIAcuity systems. The launch has a part where major new software updates are designed to expand the portfolio of applications for the use of dPCR technology in areas like cell and gene therapies, quantification of DNA and RNA, as well as food and pharmaceutical safety.

Increasing Prevalence of Infectious and Genetic Diseases

The increasing prevalence of infectious diseases like hepatitis, influenza, HIV is a significant driver for the PCR technologies market. The rise in infectious diseases and genetic diseases has led to a growing demand for PCR technologies, as they play a crucial role in the diagnosis and monitoring of these diseases. PCR is widely used in the detection of various infectious agents, including viruses, bacteria, and fungi, making it an indispensable tool in infectious disease management. PCR technologies are also used in the detection of genetic abnormalities causing genetic diseases, further fueling the market for growth.

According to WHO, about 39.0 million people were living with HIV at the end of 2022, including about 1.5 million children within the age group of 0 to 14 years. Seasonal influenza throughout the winter can infect up to 20% of the population and result in significant death. According to WHO data, respiratory illnesses associated with seasonal influenza causes up to 650,000 deaths globally each year.

Expanding Applications in Clinical Diagnosis and Genetic and Molecular Testing

PCR technology has several practical applications in the field of clinical diagnosis and in recent years, with increasing research and development, a significant expansion of PCR applications has been observed. PCR technology has been extensively utilized for COVID-19 diagnosis, driving demand in the market. Several notable applications of PCR technologies include broad-spectrum pathogen detection, assessment and surveillance of emerging infections, early detection of biological threat agents, and antimicrobial resistance analysis. Market players are coming up with innovative products for emerging applications of PCR technologies. In August 2022, GenScript USA Inc. launched a monkeypox virus PCR test kit, which was developed in partnership with Anbio Biotechnology. The kit was developed to address the monkeypox public health emergency in the United States.

Reagents and Consumables Segments are Expected to Dominate the Market

Reagents and consumables segments are expected to grow at a fast rate in the forecasted period. The instruments used for PCR tests are one-time investments while the reagents and consumables are repeatedly consumed and purchased, which drives major revenue. Reagents like primers, polymerase, nucleotides, reaction buffers, and consumables like well plates and pipette tips are consumed completely in each PCR process and need to be refilled for the next test, drawing reoccurring revenue in the market.

North America is Expected to Lead the PCR Technologies Market

North America dominates the global PCR market, with the United States and Canada holding largest market shares. The region's dominance is attributed to several factors, including extensive research infrastructure and a well-established regulatory framework that expedites approvals for new therapies. The presence of major pharmaceutical and biotechnology companies in the region has driven the development and adoption of PCR technologies. Additionally, North America has attracted significant investments in PCR research and development, enabling the establishment of state-of-the-art facilities and access to advanced technologies.

Key Players Landscape and Outlook

The market landscape for PCR technologies is growing with several key players contributing to its development and commercialization. The key players in this market include Bio-Rad Laboratories Inc., Merck KGaA, QIAGEN and others. These companies are involved in various growth strategies, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions to enhance their presence.

In September 2023, Bio-Rad Laboratories, Inc. announced the launch of two new PCR instruments named PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers. PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers are a novel addition to Bio-Rad Laboratories' portfolio of conventional PCR instruments. PTC Tempo 48/48 has the unique feature of two separate compartments with manual lids which allows two protocols to run simultaneously. The launch aims to support PCR applications in basic and translational research, process development, and quality control.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global PCR Technologies Market Outlook, 2017-2031F

  • 5.1 Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Instruments
    • 4.2.2. Reagents
    • 4.2.3. Consumables
    • 4.2.4. Software and Services
    • 4.2.5. Others
  • 4.3. By Technology
    • 4.3.1. Conventional PCR
    • 4.3.2. qPCR (Real-Time PCR)
    • 4.3.3. dPCR (Digital PCR)
    • 4.3.4. Other PCR Technologies
  • 4.4. By Application
    • 4.4.1. Research Applications
      • 4.4.1.1. Genotyping
      • 4.4.1.2. Sequencing
      • 4.4.1.3. Gene Expression
      • 4.4.1.4. Forensics
    • 4.4.2. Diagnostics Applications
    • 4.4.3. Others
  • 4.5. By End-user
    • 4.5.1. Hospital
    • 4.5.2. Diagnostic Centre
    • 4.5.3. Pharmaceutical and Biotechnology Companies
    • 4.5.4. Clinical Research Organizations
    • 4.5.5. Academia Laboratories
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East & Africa
  • 4.7. By Company Market Share (%), 2023

5. Global PCR Technologies Market Outlook, By Region, 2017-2031F

  • 5.1. North America
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Instruments
      • 5.1.2.2. Reagents
      • 5.1.2.3. Consumables
      • 5.1.2.4. Software and Services
      • 5.1.2.5. Others
    • 5.1.3. By Technology
      • 5.1.3.1. Conventional PCR
      • 5.1.3.2. qPCR (Real-Time PCR)
      • 5.1.3.3. dPCR (Digital PCR)
      • 5.1.3.4. Other PCR Technologies
    • 5.1.4. By Application
      • 5.1.4.1. Research Applications
      • 5.1.4.1.1. Genotyping
      • 5.1.4.1.2. Sequencing
      • 5.1.4.1.3. Gene Expression
      • 5.1.4.1.4. Forensics
      • 5.1.4.2. Diagnostics Applications
      • 5.1.4.3. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospital
      • 5.1.5.2. Diagnostic Centre
      • 5.1.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.5.4. Clinical Research Organizations
      • 5.1.5.5. Academia Laboratories
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
      • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Product
      • 5.1.6.2.1. Instruments
      • 5.1.6.2.2. Reagents
      • 5.1.6.2.3. Consumables
      • 5.1.6.2.4. Software and Services
      • 5.1.6.2.5. Others
      • 5.1.6.3. By Technology
      • 5.1.6.3.1. Conventional PCR
      • 5.1.6.3.2. qPCR (Real-Time PCR)
      • 5.1.6.3.3. dPCR (Digital PCR)
      • 5.1.6.3.4. Other PCR Technologies
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Research Applications
      • 5.1.6.4.1.1. Genotyping
      • 5.1.6.4.1.2. Sequencing
      • 5.1.6.4.1.3. Gene Expression
      • 5.1.6.4.1.4. Forensics
      • 5.1.6.4.2. Diagnostics Applications
      • 5.1.6.4.3. Others
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospital
      • 5.1.6.5.2. Diagnostic Centre
      • 5.1.6.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.6.5.4. Clinical Research Organizations
      • 5.1.6.5.5. Academia Laboratories
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered:

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Therapy
  • 6.2. By Technology
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis - Volume and Value
  • 7.3. Supply/Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Abbott Laboratories
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Agilent Technologies Inc.
  • 13.3. Becton, Dickinson and Company
  • 13.4. bioMerieux SA
  • 13.5. Bio-Rad Laboratories Inc.
  • 13.6. Merck KGaA
  • 13.7. PerkinElmer Inc.
  • 13.8. Promega Corporation
  • 13.9. Siemens Healthcare
  • 13.10. Thermo Fisher Scientific Inc.
  • 13.11. Danaher Corporation
  • 13.12. QIAGEN
  • 13.13. QuantuMDx Group Ltd
  • 13.14. Eppendorf

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 4. Global PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 6. Global PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global PCR Technologies Market Share (%), By Region, 2017-2031F
  • Figure 8. North America PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 10. North America PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 11. North America PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 13. North America PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 15. United States PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 17. United States PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 18. United States PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 20. United States PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 23. Canada PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 29. Mexico PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 35. Europe PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 42. Germany PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 46. France PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 48. France PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 49. France PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 50. France PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 51. France PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 54. Italy PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 60. United Kingdom PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 66. Russia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 72. Netherlands PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 78. Spain PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 84. Turkey PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 90. Poland PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 96. South America PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 97. South America PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 99. South America PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 103. Brazil PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 109. Argentina PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 115. Asia-Pacific PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 120. India PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 122. India PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 123. India PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 124. India PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 125. India PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 126. China PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 128. China PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 129. China PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 130. China PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 131. China PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 134. Japan PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 140. Australia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 146. Vietnam PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 152. South Korea PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 158. Indonesia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 164. Philippines PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 170. Middle East & Africa PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 177. Saudi Arabia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 183. UAE PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 189. South Africa PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023